Anticoagulation in Patients with End-Stage Renal Disease and Non-Valvular Atrial Fibrillation – Review Article

Anticoagulation in Patients with End-Stage Renal Disease and Non-Valvular Atrial Fibrillation – Review Article

Over the years, the number of patients with end-stage renal disease (ESRD) have been steadily increasing. Cardiovascular causes account for 55.2% of all deaths among ESRD patients. In particular, there is an increased risk of atrial fibrillation (AF) & venous thromboembolism (VTE). AF is more pr...

Full description

Bibliographic Details
Main Authors: Mahmoud Khalifa, Yara Adel Altahan, Paavana Varanasi
Format: Article
Language:English
Published: Levy Library Press 2021-05-01
Series:Journal of Scientific Innovation in Medicine
Subjects:
end stage renal disease
esrd
atrial fibrillation
anticoagulation
non valvular
dialysis
novel oral anticoagulants
noacs
direct oral anticoagulants
doacs
coumadin
warfarin
vitamin k antagonist
Online Access:https://journalofscientificinnovationinmedicine.org/articles/102

Internet

https://journalofscientificinnovationinmedicine.org/articles/102

Similar Items